140 related articles for article (PubMed ID: 33829244)
1. Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy.
Rootwelt-Norberg C; Lie ØH; Chivulescu M; Castrini AI; Sarvari SI; Lyseggen E; Almaas VM; Bogsrud MP; Edvardsen T; Haugaa KH
Europace; 2021 Jul; 23(7):1084-1091. PubMed ID: 33829244
[TBL] [Abstract][Full Text] [Related]
2. Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis.
Lie ØH; Chivulescu M; Rootwelt-Norberg C; Ribe M; Bogsrud MP; Lyseggen E; Beitnes JO; Almaas V; Haugaa KH
J Am Heart Assoc; 2021 Apr; 10(8):e018680. PubMed ID: 33821670
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study.
Lie ØH; Rootwelt-Norberg C; Dejgaard LA; Leren IS; Stokke MK; Edvardsen T; Haugaa KH
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1377-1386. PubMed ID: 30031702
[TBL] [Abstract][Full Text] [Related]
4. Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy.
Lie ØH; Dejgaard LA; Saberniak J; Rootwelt C; Stokke MK; Edvardsen T; Haugaa KH
JACC Clin Electrophysiol; 2018 Jun; 4(6):744-753. PubMed ID: 29929667
[TBL] [Abstract][Full Text] [Related]
5. Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy: Association With Life-Threatening Ventricular Arrhythmias.
Kirkels FP; Lie ØH; Cramer MJ; Chivulescu M; Rootwelt-Norberg C; Asselbergs FW; Teske AJ; Haugaa KH
JACC Cardiovasc Imaging; 2021 May; 14(5):900-910. PubMed ID: 33582062
[TBL] [Abstract][Full Text] [Related]
6. High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy.
Chivulescu M; Lie ØH; Popescu BA; Skulstad H; Edvardsen T; Jurcut RO; Haugaa KH
Eur Heart J; 2020 Apr; 41(14):1401-1410. PubMed ID: 31504415
[TBL] [Abstract][Full Text] [Related]
7. Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Wang W; Orgeron G; Tichnell C; Murray B; Crosson J; Monfredi O; Cadrin-Tourigny J; Tandri H; Calkins H; James CA
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909402
[TBL] [Abstract][Full Text] [Related]
8. Life-threatening arrhythmic presentation in patients with arrhythmogenic cardiomyopathy before and after entering the genomic era; a two-decade experience from a large volume center.
Rootwelt-Norberg C; Lie ØH; Dejgaard LA; Chivulescu M; Leren IS; Edvardsen T; Haugaa KH
Int J Cardiol; 2019 Mar; 279():79-83. PubMed ID: 30638987
[TBL] [Abstract][Full Text] [Related]
9. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
Eur Heart J; 2019 Jun; 40(23):1850-1858. PubMed ID: 30915475
[TBL] [Abstract][Full Text] [Related]
10. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
[TBL] [Abstract][Full Text] [Related]
11. Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study.
Rootwelt-Norberg C; Skjølsvik ET; Chivulescu M; Bogsrud MP; Ribe MP; Aabel EW; Beitnes JO; Brekke PH; Håland TF; Hasselberg NE; Lie ØH; Haugaa KH
Europace; 2023 Feb; 25(2):634-642. PubMed ID: 36352512
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
14. Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse.
Five CK; Hasselberg NE; Aaserud LT; Castrini AI; Vlaisavljevic K; Lie Ø; Rootwelt-Norberg C; Aabel EW; Haugaa KH
Europace; 2023 Oct; 25(10):. PubMed ID: 37851515
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
[TBL] [Abstract][Full Text] [Related]
16. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
17. The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy.
Kirkels FP; Rootwelt-Norberg C; Bosman LP; Aabel EW; Muller SA; Castrini AI; Taha K; van Osta N; Lie ØH; Asselbergs FW; Lumens J; Te Riele ASJM; Hasselberg NE; Cramer MJ; Haugaa KH; Teske AJ
Eur Heart J Cardiovasc Imaging; 2023 Nov; 24(12):1710-1718. PubMed ID: 37474315
[TBL] [Abstract][Full Text] [Related]
18. Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy.
Castrini AI; Lie ØH; Leren IS; Estensen ME; Stokke MK; Klæboe LG; Edvardsen T; Haugaa KH
Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):192-198. PubMed ID: 29659777
[TBL] [Abstract][Full Text] [Related]
19. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
20. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
Calkins H; Corrado D; Marcus F
Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
